New scan could tell doctors if chemo worked without surgery
NCT ID NCT07593976
First seen May 21, 2026 · Last updated May 21, 2026
Summary
This study tests a special PET/CT scan that uses a radioactive tracer to see if HER2-positive breast cancer has been completely eliminated by chemotherapy before surgery. About 42 women with early-stage breast cancer will receive the scan after their chemo. The goal is to see if the scan can accurately predict which patients have no cancer left, potentially helping doctors tailor treatments more precisely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Henri Becquerel
Rouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.